Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Upstream Completes Transaction with Drayer Physical Therapy Institute
-
Optinose Announces $100 Million Debt Financing from Athyrium Capital Management
-
Optinose Announces $100 Million Debt Financing from Athyrium Capital Management
-
Energy Fuels Renews Its ATM Program
-
Cantor Fitzgerald Downgrades Ignyta, Inc (RXDX) to Neutral Following Acquisition
-
Horizon Pharma (HZNP) Expanded Procysbi Label Highlighting The Importance Of Treating Early - Cantor Fitzgerald
-
Glaukos Corporation (GKOS) PT Lowered to $48 at Cantor Fitzgerald
-
BGC Partners And Newmark Group Announce Exercise And Closing Of Overallotment Option For The Newmark Group Initial Public Offering
-
Valeant Pharmaceuticals (VRX) 2018 Outlook 'Keeps Getting Better' - Cantor Fitzgerald
-
Mallinckrodt's (MNK) Sucampo Acquisition 'Is A Smart Strategic Deal' - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group (UNH) Following 8-K Filing
-
Agile Therapeutics (AGRX) PT Lowered to $5 at Cantor Fitzgerald
-
Accenture plc (ACN) PT Raised to $180 at Cantor Fitzgerald Following Strong 1Q
-
Cantor Fitzgerald Starts Tier Technologies (TIER) at Overweight, 'A Transformed Portfolio Positioned for Growth'
-
Form 4 NEWMARK GROUP, INC. For: Dec 13 Filed by: CANTOR FITZGERALD, L. P.
-
Form 4 BGC Partners, Inc. For: Dec 13 Filed by: CANTOR FITZGERALD, L. P.
-
ProPhotonix Director/PDMR Shareholding
-
Prothena Corp (PRTA) PT Lowered to $65 at Cantor Fitzgerald; Reiterates Overweight
-
Cantor Fitzgerald Starts Omega Healthcare Investors (OHI) at Overweight
-
Apollo Endosurgery (APEN) Files to Offer $16M in Common Stock
-
Helen of Troy (HELE) Sold Healthy Directions LLC to Direct Digital LLC for Up to $71M
-
Helen of Troy Announces the Sale of Healthy Directions LLC
-
Perella Weinberg Partners Announces New Partners
-
Freddie Mac Prices $182 Million Multifamily K-Deal, K-J18
-
FactSet Research Systems (FDS) PT Raised to $187 at Cantor Fitzgerald Following 1Q
-
Intermex Holdings II, Inc. and FinTech Acquisition Corp. II (FNTE) Announce Merger Agreement
-
BGC Partners Updates Its Outlook For The Fourth Quarter Of 2017
-
Intermex Holdings II, Inc. and FinTech Acquisition Corp. II Announce Merger Agreement Combining Businesses
-
TherapeuticsMD (TXMD) PT Lowered to $28 at Cantor Fitzgerald
-
Intermex Holdings II, Inc. and FinTech Acquisition Corp. II Announce Merger Agreement Combining Businesses
-
McEwen Mining Announces Closing of Financing
-
BGC Partners and Newmark Group Announce Closing of Newmark Group Initial Public Offering
-
McEwen Mining Announces Closing of Financing
-
Cantor on Spark Therapeutics (ONCE): 'The FDA Could Not Resist LUXTURNA', Price Target $105
-
Pershing Gold Corporation. (PGLC) Closes Bought Deal Of US$7.8 Million And Private Placement of $6.8M
-
Pershing Gold Closes Bought Deal Of US$7.8 Million And Private Placement Of US$6.8 Million
-
Aerie Pharma (AERI) PT Raised to $77 at Cantor Fitzgerald following FDA approval of Rhopressa
-
ProPhotonix has Achieved ISO9001:2015
-
WellCare Health Plans (WCG) PT Raised to $235 at Cantor Fitzgerald, Defends Equity, Says 'Selloff Overdone'
-
Centene (CNC) PT Raised to $115 at Cantor Fitzgerald Following 'Impressive' 2018 Guidance
-
Newmark Group (NMRK) IPO Opens Flat
-
Pre-Open Movers 12/15: (DDR) (ALNY) (HES) Higher; (TROV) (VSTM) (CSX) Lower (more...)
-
Global Blood Therapeutics (GBT) Says it Priced $100M Common Stock Offering
-
Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering
-
Rosetta Genomics (ROSG) Agrees to Sell Business to Genoptix for $10M
-
Genoptix to Acquire Rosetta Genomics for $10 Million in Cash
-
BGC Partners And Newmark Group Announce Pricing Of Newmark Group Initial Public Offering
-
Form 3 NEWMARK GROUP, INC. For: Dec 14 Filed by: CANTOR FITZGERALD, L. P.
-
After-Hours Stock Movers 12/14: (DDR) (HES) (DISCA) Higher; (VSTM) (APHB) (ORCL) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Rigel Pharmaceuticals (RIGL) at Overweight

